[HTML][HTML] Emerging mechanisms and targeted therapy of ferroptosis in cancer
H Wang, Y Cheng, C Mao, S Liu, D Xiao, J Huang… - Molecular Therapy, 2021 - cell.com
Ferroptosis is an iron-and lipid reactive oxygen species (ROS)-dependent form of
programmed cell death that is distinct from other forms of regulatory cell death at the …
programmed cell death that is distinct from other forms of regulatory cell death at the …
[HTML][HTML] Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Y Yang, S Li, Y Wang, Y Zhao, Q Li - Signal transduction and targeted …, 2022 - nature.com
Protein tyrosine kinases (PTKs) are a class of proteins with tyrosine kinase activity that
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …
phosphorylate tyrosine residues of critical molecules in signaling pathways. Their basal …
[HTML][HTML] MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
R Sigaud, TK Albert, C Hess, T Hielscher… - Nature …, 2023 - nature.com
Pediatric low-grade gliomas (pLGG) show heterogeneous responses to MAPK inhibitors
(MAPKi) in clinical trials. Thus, more complex stratification biomarkers are needed to identify …
(MAPKi) in clinical trials. Thus, more complex stratification biomarkers are needed to identify …
BRAFΔβ3-αC in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
M Lauinger, D Christen, RFU Klar, C Roubaty… - Science …, 2023 - science.org
In-frame BRAF exon 12 deletions are increasingly identified in various tumor types. The
resultant BRAFΔβ3-αC oncoproteins usually lack five amino acids in the β3-αC helix linker …
resultant BRAFΔβ3-αC oncoproteins usually lack five amino acids in the β3-αC helix linker …
[HTML][HTML] Selective anti-cancer effects of plasma-activated medium and its high efficacy with cisplatin on hepatocellular carcinoma with cancer stem cell characteristics
Hepatocellular carcinoma (HCC) is a major histological subtype of primary liver cancer.
Ample evidence suggests that the pathological properties of HCC originate from hepatic …
Ample evidence suggests that the pathological properties of HCC originate from hepatic …
[HTML][HTML] The interactions between integrin α5β1 of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis
Z Peng, M Hao, H Tong, H Yang, B Huang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) progression is closely related to pathological fibrosis,
which involves heterotypic intercellular interactions (HIIs) between liver cancer cells and …
which involves heterotypic intercellular interactions (HIIs) between liver cancer cells and …
[HTML][HTML] Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
X Qing, W Xu, J Zong, X Du, H Peng, Y Zhang - Biomarker Research, 2021 - Springer
Hepatocellular carcinoma (HCC) has long been a major global clinical problem as one of
the most common malignant tumours with a high rate of recurrence and mortality. Although …
the most common malignant tumours with a high rate of recurrence and mortality. Although …
An overview: management of patients with advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) has constituted a significant health burden worldwide, and
patients with advanced HCC, which is stage C as defined by the Barcelona Clinic Liver …
patients with advanced HCC, which is stage C as defined by the Barcelona Clinic Liver …
Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
S Sinha, N Hassan, RE Schwartz - Hepatology, 2024 - journals.lww.com
The synchronous functioning and quality control of organelles ensure cell survival and
function and are essential for maintaining homeostasis. Prolonged exposure to stressors …
function and are essential for maintaining homeostasis. Prolonged exposure to stressors …
Experimental drug treatments for hepatocellular carcinoma: clinical trial failures 2015 to 2021
Introduction Hepatocellular carcinoma (HCC) is a major health problem worldwide with
limited systemic therapy options. Since the approval of sorafenib in 2008, no systemic …
limited systemic therapy options. Since the approval of sorafenib in 2008, no systemic …